|
1
|
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
|
Ann Rheum Dis
|
2010
|
2.71
|
|
2
|
Risk of non-Hodgkin lymphoma in celiac disease.
|
JAMA
|
2002
|
1.81
|
|
3
|
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.
|
PLoS Genet
|
2011
|
1.77
|
|
4
|
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.
|
Arthritis Rheum
|
2011
|
1.56
|
|
5
|
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group.
|
Arthritis Res Ther
|
2012
|
1.44
|
|
6
|
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies.
|
J Rheumatol
|
2010
|
1.17
|
|
7
|
Ultrasound evaluation of ulnar neuropathy at the elbow: correlation with electrophysiological studies.
|
Rheumatology (Oxford)
|
2009
|
1.08
|
|
8
|
Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
|
Arthritis Rheum
|
2012
|
1.06
|
|
9
|
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.
|
Ann Rheum Dis
|
2011
|
1.00
|
|
10
|
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.
|
Br J Haematol
|
2004
|
0.97
|
|
11
|
Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients.
|
J Rheumatol
|
2010
|
0.95
|
|
12
|
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
|
Thromb Haemost
|
2014
|
0.93
|
|
13
|
Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
|
Arthritis Rheum
|
2007
|
0.93
|
|
14
|
Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
|
Clin Biochem
|
2007
|
0.93
|
|
15
|
Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis.
|
Joint Bone Spine
|
2009
|
0.91
|
|
16
|
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis.
|
Ann Rheum Dis
|
2012
|
0.88
|
|
17
|
A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.
|
Arthritis Rheum
|
2013
|
0.87
|
|
18
|
Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
|
Proteomics Clin Appl
|
2011
|
0.85
|
|
19
|
Evaluation of cardiac laboratory markers in patients with systemic sclerosis.
|
Clin Biochem
|
2006
|
0.85
|
|
20
|
A case-control study of occupational exposures and systemic sclerosis.
|
Int Arch Occup Environ Health
|
2003
|
0.84
|
|
21
|
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.
|
J Rheumatol
|
2013
|
0.83
|
|
22
|
Pancreatic granulomatous necrotizing vasculitis: a case report and review of the literature.
|
Rheumatol Int
|
2007
|
0.81
|
|
23
|
Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis.
|
Rheumatol Int
|
2009
|
0.81
|
|
24
|
Hydroxychloroquine-induced DRESS syndrome.
|
Clin Rheumatol
|
2007
|
0.80
|
|
25
|
Psoriasis onset during infliximab treatment: description of two cases.
|
Rheumatol Int
|
2006
|
0.80
|
|
26
|
Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study.
|
Rheumatology (Oxford)
|
2011
|
0.80
|
|
27
|
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis.
|
Clin Chim Acta
|
2005
|
0.80
|
|
28
|
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
|
PLoS One
|
2010
|
0.80
|
|
29
|
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study.
|
Arthritis Rheum
|
2011
|
0.80
|
|
30
|
[HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations].
|
Recenti Prog Med
|
2005
|
0.79
|
|
31
|
Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease.
|
Rheumatol Int
|
2008
|
0.79
|
|
32
|
[Homocysteine and rheumatic disease].
|
Recenti Prog Med
|
2007
|
0.78
|
|
33
|
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.
|
Clin Exp Rheumatol
|
2011
|
0.78
|
|
34
|
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study.
|
Mod Rheumatol
|
2015
|
0.77
|
|
35
|
Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients.
|
J Rheumatol
|
2008
|
0.76
|
|
36
|
Plasma D-dimer concentration in patients with systemic sclerosis.
|
Thromb J
|
2006
|
0.75
|
|
37
|
Systemic sclerosis and malignancy.
|
South Med J
|
2008
|
0.75
|
|
38
|
Vitamin D and autoimmune rheumatic diseases.
|
Clin Rheumatol
|
2011
|
0.75
|
|
39
|
Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases.
|
J Rheumatol
|
2013
|
0.75
|
|
40
|
The ambitious goal of validating prognostic biomarkers for systemic sclerosis-related interstitial lung disease.
|
J Rheumatol
|
2013
|
0.75
|
|
41
|
Desensitization to hydroxychloroquine: 4 cases.
|
J Rheumatol
|
2011
|
0.75
|
|
42
|
[Neutrophils in rheumatoid inflammation].
|
Recenti Prog Med
|
2003
|
0.75
|
|
43
|
B-flow ultrasound in a case of giant cell arteritis.
|
Clin Rheumatol
|
2007
|
0.75
|
|
44
|
Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.
|
Joint Bone Spine
|
2009
|
0.75
|
|
45
|
Iloprost infusion does not reduce oxidative stress in systemic sclerosis.
|
Rheumatol Int
|
2007
|
0.75
|
|
46
|
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis.
|
Rheumatology (Oxford)
|
2013
|
0.75
|
|
47
|
Unusual bridge ossification of pubic symphysis in diffuse idiopathic skeletal hyperostosis.
|
Rheumatol Int
|
2011
|
0.75
|
|
48
|
Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report.
|
Joint Bone Spine
|
2010
|
0.75
|
|
49
|
Low levels of activated factor VII in systemic sclerosis.
|
J Thromb Thrombolysis
|
2006
|
0.75
|
|
50
|
Thyroid status in patients with systemic sclerosis.
|
J Clin Rheumatol
|
2006
|
0.75
|
|
51
|
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients.
|
Ann Rheum Dis
|
2012
|
0.75
|